Twin Cities, MN— October 5th, 2023 — Biomedix, a market-leading medical technology and innovation company, was invited to screen congressional representatives and their staff at the United States Capitol with PADnet Xpress during the PAD Caucus briefing on September 27th, 2023. PAD Caucus Co-Chairs, Congressman Donald Payne, Jr. and Congressman Read more…
Background: Biomedix is a leading medical device and healthcare risk-assessment technology company with a portfolio of diagnostic devices and services that help guide patient care and eliminate gaps between the cost of care and compensation for care. We are seeking talented individuals to join our sales team in this exciting Read more…
Innovative Leasing Program for MiniOmni Osteoporosis Screening Twin Cities, MN— August 25th, 2023 —Biomedix, a market-leading medical technology and innovation company, and BeamMed, a developer, manufacturer and marketer of best-in-class bone density assessment solutions, announced a new strategic partnership to assist value-based care organizations close OMW and OSW HEDIS gaps. Read more…
Position: Client Support Specialist Background: Biomedix is a leading medical device and healthcare risk-assessment technology company with a portfolio of diagnostic devices and services that help guide patient care and eliminate gaps between the cost of care and compensation for care. We are seeking talented individuals to join our service Read more…
At Biomedix, we strive to promote top-notch vascular care and have compiled the reimbursement rates for PADnet tests, including CPT codes 93922, 93923, and 93924, as well as office visit E/M codes, for the year 2023. Market-by-market data has been gathered and the published Medicare reimbursement rates are available. This Read more…
FDA Clearance For PADnet Xpress For Home Use Twin Cities, MN— November 30th, 2022 — Biomedix, a market-leading medical technology and innovation company, announced that the PADnet Xpress device has received clearance from the FDA for use in the home. “We are excited to announce the expanded clearance for in-home use of Read more…
A study recently published in the Journal of the American Podiatric Medical Association examined the combined utility of a timed vibration test (TVT) combined with monofilament, and compared the effectiveness of using these technologies separately to predict diabetic foot ulcers (DFU) accurately. The study involved 200 patients, 24 which developed Read more…
Stop by booth 308 to check out PADnet Xpress, the world’s best cuff-free vascular disease diagnostic technology. Make sure to stop by our roundtable 8-9am on Wednesday, March 9th, titled: Boosting HCC capture and gap closure during clinical encounters with point-of-care technology.
If you are going to ACFAS February 24th-26th, schedule some time to meet with the Biomedix team, we’ll be there! Schedule A Time
Oftentimes, vascular testing is billed at CPT codes 93922, 93923, and 93924. However, using PADnet for vascular testing unlocks the opportunity to bill an additional code to boost per-test reimbursement by 33% when billing for a full arterial study with PADnet (CPT code 93923). Register now to discover the details Read more…